Human Papillomavirus (HPV) News and Research

Latest Human Papillomavirus (HPV) News and Research

Study looks at reproductive health of girls who developed HIV at birth

A generation of children born with HIV are now coming of age and reaching sexual maturity. Girls in this group who are sexually active are experiencing a higher number than expected of cervical abnormalities, a new study finds.

27 Apr 2007

Factors that dictate risk of developing primary or secondary cancer

Every day, people make assumptions, educated and not, about their risk for developing cancer.

18 Apr 2007

Taking a jab at cancer by stimulating the immune system

As the first FDA-approved cancer vaccine, designed to protect against human papillomavirus, has moved from scientific discussion to social debate, other vaccine studies are continuing to make progress.

18 Apr 2007

Predicting cancer risk in the long term

Every day, people make assumptions, educated and not, about their risk for developing cancer.

17 Apr 2007

BioForce Nanosciences pursues support for ViriChip platform

BioForce Nanosciences continues their effort to fund development of the ViriChip platform, a patented system designed to rapidly and nondestructively detect and identify whole viruses.

12 Apr 2007

Roche and Transgene S.A. partner on HPV vaccine program

Roche and Transgene S.A. have announced that they have entered into an exclusive worldwide collaboration agreement to develop and commercialize products from Transgene's therapeutic vaccine program against Human Papilloma Virus-mediated diseases.

11 Apr 2007

HPV scientists to be honored

The potential for a new vaccine to eliminate cervical cancer caused by the human papillomavirus, or HPV, will be celebrated during the James P. Wilmot Cancer Center's eighth annual Discovery Ball on Saturday, April 28, at the Rochester Riverside Convention Center.

11 Apr 2007

Experimental flu vaccine produced using insect cells shows promise

An influenza vaccine produced with the use of insect cells appeared safe and produced an immunogenic response in healthy adults, suggesting promise as an alternative to using embryonated eggs for the development of influenza vaccine, according to a preliminary study in the April 11 issue of JAMA.

11 Apr 2007

Montefiore Medical Center launches human papilloma virus clinic

The only HPV (Human Papilloma Virus) Vaccine Clinic of its kind has been launched at Montefiore Medical Center.

7 Apr 2007

Takeda acquires rights for drug to treat cervical dysplasia, HPV

Japanese pharmaceutical company Takeda on Friday announced that it has acquired from 3M the rights for a drug, called R-851, to treat cervical dysplasia and "high-risk" human papillomavirus infection, Reuters reports.

2 Apr 2007

New York progresses HPV vaccine distribution to health providers, school clinics

The New York City Department of Health and Mental Hygiene on Thursday announced that it has distributed 57,810 doses of Merck's human papillomavirus vaccine Gardasil to city health providers, including school-based health clinics, the New York Post reports.

2 Apr 2007

GlaxoSmithKline submits Biologics License Application (BLA) for CERVARIX

If licensed, the vaccine will be indicated for the prevention of cervical cancer and precancerous lesions associated with the most common cancer-causing human papillomavirus types.

1 Apr 2007

HPV vaccine proposals in Florida, Georgia, North Carolina, South Dakota

Merck's HPV vaccine Gardasil and GlaxoSmithKline's HPV vaccine Cervarix in clinical trials have been shown to be 100% effective in preventing infection with HPV strains 16 and 18, which together cause about 70% of cervical cancer cases.

22 Mar 2007

Canada budgets $258 million for human papillomavirus vaccination programs

The Canadian government on Monday announced that it is including about $258 million in the 2007-2008 budget to help pay for provincial human papillomavirus vaccination programs, Toronto's Globe and Mail reports.

22 Mar 2007

AACR's Sixth Annual Landon Awards recognize Richard Kolodner, Douglas Lowy and John Schiller

Scientists whose discoveries have led to fundamental advances in the science and treatment of cancer are the recipients of two prestigious international prizes offered by the Kirk A. and Dorothy P. Landon Foundation and the American Association for Cancer Research.

22 Mar 2007

Lack of preventive care, not HPV vaccine, 'real' reason 'too many women still die of cervical cancer'

The "real" reason that "[t]oo many women still die of cervical cancer" is the "lack of access to preventive medical care for low-income women and not the lack of a vaccine," Wall Street Journal columnist and Illinois-based physician Benjamin Brewer writes in an opinion piece.

11 Mar 2007

Gardasil not provided at most New York City health clinics

Merck's human papillomavirus vaccine Gardasil is not provided at most New York City health clinics, and girls and women who are eligible for no-cost or low-cost vaccination often are told they must pay for it, according to a report released on Wednesday by Public Advocate Betsy Gotbaum, the New York Sun reports.

11 Mar 2007